Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.

Documenti analoghi

• Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
  di: Chen, Xiaohui, et al.
  Pubblicazione: (2025)
• Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.
  di: Mao, Churu, et al.
  Pubblicazione: (2026)
• Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
  di: Du, Lin, et al.
  Pubblicazione: (2025)
• Supplementary data for "The histone code of love: epigenetics of maturation of gonads in the human blood fluke Schistosoma mansoni"
  di: Grunau, Christoph
  Pubblicazione: (2026)
• Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
  di: Cao, Yin, et al.
  Pubblicazione: (2025)